Skip to main content
$263.04 $1.59 (0.6%)

04:00 PM EDT on 10/21/21

ResMed, Inc. (NYSE:RMD)

CAPS Rating: 4 out of 5

The Company is a developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.

Current Price $263.04 Mkt Cap $38.3B
Open $262.03 P/E Ratio 80.55
Prev. Close $263.04 Div. (Yield) $1.68 (0.6%)
Daily Range $259.55 - $263.45 Volume 1,611
52-Wk Range $177.70 - $301.34 Avg. Daily Vol. 537,153

Caps

How do you think NYSE:RMD will perform against the market?

Add Stock to CAPS Watchlist

All Players

284 Outperform
14 Underperform
 

All-Star Players

84 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:RMD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFSpiffyPop (99.88)
Submitted April 26, 2017

Picked on my 4/19/17 Rule Breaker Investing podcast as as a stock I like for the next three years. Outperform.

1simplemind (32.01)
Submitted November 29, 2007

I am a Medicare provider of ResMed's line of products and have done so for the past 8 years. Medicare and the other insurers are shrinking the reimbursements to providers of this product (me) as the boomer population increases. Watch for the margins… More

Recent Community Commentary

Read the most recent pitches from players about RMD.

Recs

0
Member Avatar TMFbonefish (62.99) Submitted: 7/27/2021 10:33:32 AM : Outperform Start Price: $262.69 NYSE:RMD Score: -3.32

Sleep Apnea and COPD aren't ailments that are going anywhere. In fact, so many are undiagnosed, the market will likely grow much faster than the prevalence of the conditions. Add in a shift to connected devices through software and it seems like ResMed is a great example of how every company is a technology company these days. It's an old school company transforming before our eyes.

Recs

0
Member Avatar TMFjimhalley (< 20) Submitted: 4/12/2021 7:40:48 PM : Outperform Start Price: $197.77 NYSE:RMD Score: +22.76

The growth of diagnosis in sleep apnea bodes well for the company. In addition, a lot of sleep apnea diagnoses were put off last year and that will help the company's bottom line this year.

Recs

0
Member Avatar chessNstocks (25.64) Submitted: 2/26/2021 7:44:45 AM : Outperform Start Price: $194.54 NYSE:RMD Score: +17.17

Fool favorite that meets all my Buy criteria.
Price/Sales (TTM) = 9.1
Revenue Growth (5YR) = 12%
Rev Change (Last Qtr vs Prior year Qtr) = 8.7%

Leaderboard

Find the members with the highest scoring picks in RMD.

Score Leader

macchiatto

macchiatto (56.85) Score: +1,317.90

The Score Leader is the player with the highest score across all their picks in RMD.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
macchiatto 56.85 7/17/2008 Outperform 3M $15.54 +1,592.97% +275.07% +1,317.90 0 Comment
schwah9 61.63 10/13/2008 Outperform NS $14.96 +1,657.72% +395.84% +1,261.88 0 Comment
chipiii3 < 20 6/16/2008 Outperform 3W $16.43 +1,500.50% +246.06% +1,254.43 0 Comment
AIAbram < 20 8/4/2008 Outperform 3W $16.24 +1,520.14% +274.82% +1,245.33 0 Comment
rylin100 82.91 6/2/2008 Outperform NS $16.69 +1,475.96% +236.47% +1,239.48 0 Comment
kurzzz 92.54 10/23/2008 Outperform 1Y $15.09 +1,643.13% +415.53% +1,227.60 1 Comment
raideral < 20 7/2/2008 Outperform 1Y $16.66 +1,479.19% +263.08% +1,216.11 0 Comment
alpot < 20 7/2/2008 Outperform 1Y $16.66 +1,479.19% +263.08% +1,216.11 0 Comment
brodie82 56.62 7/9/2008 Outperform 1Y $16.66 +1,478.81% +267.16% +1,211.65 0 Comment
bcorbett8769 46.65 7/2/2008 Outperform 1Y $16.68 +1,476.56% +265.58% +1,210.98 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for RMD.